Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study-Reference-Cited by-同舟云学术

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

Published:2017-02 Issue:2 Volume:71 Page:151-154
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Beer Tomasz M.,Armstrong Andrew J.,Rathkopf Dana,Loriot Yohann,Sternberg Cora N.,Higano Celestia S.,Iversen Peter,Evans Christopher P.,Kim Choung-Soo,Kimura Go,Miller Kurt,Saad Fred,Bjartell Anders S.,Borre Michael,Mulders Peter,Tammela Teuvo L.,Parli Teresa,Sari Suha,van Os Steve,Theeuwes Ad,Tombal Bertrand

Publisher

Elsevier BV

Subject

Urology

Reference6 articles.

1. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

2. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014

3. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

4. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N Engl J Med,2013

5. Long-term safety and antitumor activity in the phase 1-2 study of enzalutamide in pre- and post-docetaxel castration-resistant prostate cancer;Higano;Eur Urol,2015

Cited by 323 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

2. An Inherited Allele Confers Prostate Cancer Progression and Drug Resistance via RFX6/HOXA10‐Orchestrated TGFβ Signaling;Advanced Science;2024-06-26

3. Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management;Current Treatment Options in Oncology;2024-06-24

4. Cardiovascular Toxicity Associated With Androgen Receptor Axis-Targeted Agents in Patients With Prostate Cancer: A Meta-analysis of Randomized Controlled Trials;Clinical Genitourinary Cancer;2024-06

5. Combination of miR-99b-5p and Enzalutamide or Abiraterone Synergizes the Suppression of EMT-Mediated Metastasis in Prostate Cancer;Cancers;2024-05-19